Treace Medical Concepts Inc. Common Stock (TMCI)

About TMCI

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bun…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

450

Website

www.treace.com/

Fundamentals

1-day range

$4.55$4.78

Market cap

$303.61M

P/E (trailing)

—

P/E (forward)

-5.47

EPS (trailing)

$-0.96

Dividend yield

—

Beta

1.48

Avg. volume

684.4K

Forecasts

3 analyst ratings

Treace Medical Concepts Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• TMCI

  Treace Medical Concepts Inc. Common Stock

  $4.67

  ▲ 1.41%
  Market cap $303.61MP/E —
  $1.17$7.63
• PROF

  Profound Medical Corp. Common Stock

  $6.86

  ▼ 1.44%
  Market cap $299.42MP/E —
  $5.23$12.4
• MOBI

  Mobia Medical Inc. Common Stock

  $11.37

  ▲ 7.22%
  Market cap $377.38MP/E —
  $10.19$15.29
• PDEX

  Pro-Dex Inc. Common Stock

  $62.37

  ▼ 3.85%
  Market cap $203.09MP/E 17.93
  $23.47$69.86
• LUCD

  Lucid Diagnostics Inc. Common Stock

  $0.9989

  ▲ 1.51%
  Market cap $196.65MP/E —
  $0.8605$1.63
• APYX

  Apyx Medical Corporation Common Stock

  $3.08

  ▲ 2.67%
  Market cap $175.19MP/E —
  $1.7$5.08
• NPCE

  Neuropace Inc. Common Stock

  $14.41

  ▲ 1.98%
  Market cap $460.27MP/E —
  $8.76$19.6

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5
  benzinga · 8/10/2026
• Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5
  Benzinga · 8/10/2026
• Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/7/2026
• Treace Medical Concepts (NASDAQ:TMCI) Rises as Q2 Loss Narrows, Revenue Matches Estimates
  ChartMill · 8/7/2026
• Treace Medical Concepts Q2 EPS $(0.24) Beats $(0.30) Estimate, Sales $45.376M Beat $44.020M Estimate
  Benzinga · 8/7/2026
• Treace Medical Concepts Raises FY2026 Sales Guidance from $202.000M-$212.000M to $204.000M-$212.000M vs $206.220M Est
  Benzinga · 8/7/2026

• Scanlan Sean F. · August 9, 2026 · Tax Withholding

  9.8K
• Hair Mark · August 9, 2026 · Tax Withholding

  37.1K
• Elder Scot Michael · August 9, 2026 · Tax Withholding

  16.3K
• Treace John T. · June 11, 2026 · Buy

  9.9K @ $4.04
• Treace John T. · June 11, 2026 · Buy

  22.9K @ $4.04
• Treace John T. · June 10, 2026 · Buy

  14.7K @ $4.02
• Treace John T. · June 10, 2026 · Buy

  29.4K @ $4.02
• Treace John T. · June 1, 2026 · Buy

  50.0K @ $3.56
• Treace John T. · May 28, 2026 · Buy

  61.2K @ $3.02
• Treace John T. · May 27, 2026 · Buy

  49.8K @ $2.87
• Treace John T. · May 26, 2026 · Buy

  4.5K @ $2.79
• Jain Deepti · May 19, 2026 · Grant

  30.0K
• Hanna Betsy · May 19, 2026 · Grant

  30.0K
• Berry Lance A · May 19, 2026 · Grant

  30.0K
• Kiernan Jane E · May 19, 2026 · Grant

  30.0K

Institutional Ownership

March 31, 2026

Total shares held

35.19M

Total value held

$45.42M

Institutional holders

113